CovalX AG was founded in 2006. The company's vision is to become a leading provider of technology and services in the field of epitope mapping and protein interaction analysis based on mass spectrometry. With support offices in Switzerland, France, and the USA, we are a global company offering leading products and services for major pharmaceutical companies as well as academic laboratories. Our High Mass Systems and services are sold worldwide through direct offices (Europe, USA) or distributors (China, Japan). CovalX is a fast-growing company, developing innovative analysis solutions for the characterization of therapeutic proteins and protein interactions for the life science industry. To learn more about our services and products, feel free to reach out to us via infona@covalx.com, +1(617) 297 2263, or Contact Us form.